Medifast, Inc. (NYSE: MED) is a Consumer Cyclical company (Personal Products & Services) with a market capitalization of $136M. The Maz Rating grades it against the other companies in its sector.
About three months ago (August 17, 2026), Medifast, Inc. had a Maz Rating of 2.21 out of 5 (C, Hold), ranked against the other companies in its sector. Its strongest factor then was Valuation (4.56), among the most attractively valued in its sector; its weakest was Growth (1.42), among the weakest in its sector. The other factors: Financial Health 4.34 (above most of its sector); Momentum 2.42 (below most of its sector); Profitability 2.33 (below most of its sector). The current rating is for members: log in to see it.
At $12.19, Medifast, Inc. trades at 0.5x sales and 0.8x book value. Over the last twelve months it generated about $298M of revenue and a net loss of $41M. It runs a gross margin of 69.2%, an operating margin of -10.9% and a net margin of -13.6%. It shows return on equity of -21.1%, return on invested capital of -16.2% and a free cash flow yield of -2.8%. On the balance sheet: a debt-to-equity ratio of 0.11 and a current ratio of 4.82. Over the past 52 weeks the share price ranged from $9.22 to $13.63, with a beta of 0.69.
Medifast, Inc. does not currently pay a dividend.
12 Wall Street analyst ratings cover the stock: 4 Buy, 6 Hold and 2 Sell, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.